Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-41.43%
↓ 110% vs avg
Percentile
P18
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-19.75%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -41.43% |
| Q3 2025 | 30.34% |
| Q2 2025 | -23.88% |
| Q1 2025 | -40.09% |
| Q4 2024 | 12.00% |
| Q3 2024 | -0.39% |
| Q2 2024 | 7.17% |
| Q1 2024 | -70.08% |
| Q4 2023 | -90.95% |
| Q3 2023 | 17.81% |
| Q2 2023 | -37.45% |
| Q1 2023 | 0.00% |